PHAR vs VTYX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
PHAR Captures Institutional Edge (2โ2 Pillars ยท 5โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Pharming Group N.V. ADS, each representing 10 ordinary shares (PHAR) driven by superior Valuation, Growth & Margin while VTYX counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, PHAR trades at N/M Forward P/E with 12.8% operating margin (+20.8% YoY revenue) versus VTYX at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, PHAR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against VTYX sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | PHAR | VTYX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $891.8M | $1.0B | Larger Scale | VTYX |
| Trailing P/E Ratio Valuation | 39.4x | N/M | Lower Multiple | PHAR |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +20.8% | +0.0% | Higher Growth | PHAR |
| Operating Margin (TTM) Profitability | 12.8% | 0.0% | Higher Margin | PHAR |
| Net Profit Margin Profitability | 6.2% | 0.0% | Higher Margin | PHAR |
| Return on Equity (ROE) Capital Efficiency | 8.7% | -45.4% | Higher ROE | PHAR |
| 52-Week Range Position Momentum | 28% ($9โ$21) | 55% ($1โ$25) | Stronger Trend | VTYX |
| Beta / 30D Volatility Risk Regime | 0.83ฮฒ ยท 60% Vol | 2.07ฮฒ ยท 2% Vol | Lower Realized Risk | VTYX |
| Unified Institutional Score Composite Signal | 36.2 / 100 (SELL) | 50.4 / 100 (HOLD) | Higher Composite | VTYX |